- Appoints Accomplished Life Sciences Executive Christina Rossi to its Board of Directors - IRVINE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical ...
CG Oncology, Inc. (NASDAQ:CGON) announced changes to its board of directors this week, according to a statement based on a recent SEC filing. The clinical-stage biotechnology company, currently valued ...
IRVINE, Calif. - CG Oncology, Inc. (NASDAQ:CGON), a late-stage clinical biopharmaceutical company focused on bladder cancer therapeutics, announced Wednesday the appointment of Christina Rossi to its ...